TY - JOUR
T1 - Ethics in transfusion medicine
T2 - Are the intricate layers of ethics all universal? A global view
AU - Garraud, Olivier
AU - Politis, Constantina
AU - Henschler, Reinhard
AU - Vlaar, Alexander P. J.
AU - Haddad, Antoine
AU - Ertuğrul Örüç, Nigar
AU - Laspina, Stefan
AU - de Angelis, Vincenzo
AU - Richardson, Clive
AU - the European, Mediterranean Initiative in Transfusion medicine EMITm collaborative
AU - Vuk, Tomislav
N1 - Publisher Copyright: © 2023 Société française de transfusion sanguine (SFTS)
PY - 2023/8
Y1 - 2023/8
N2 - Ethical principles have been considered, and in several respects regulated, along the entire blood procurement chain from donor motivation to transfusion to the patient. Consent of donors and voluntary non-remunerated donation are fields which have been addressed by codes of ethics and legislation. Caring for donor health is an area of further development of ethical standards. In part, blood products have also become a market, where commercial principles may synergize, but also creating issues in equality and maintaining human dignity that challenge societal solutions. At the bedside, the main global challenge remains to procure enough blood products for each patient in medical need. Allocation of rare blood, ethical evaluation of transfusion triggers, attitudes towards refusing blood transfusion and provision of blood products to remote settings are areas which should receive consideration.
AB - Ethical principles have been considered, and in several respects regulated, along the entire blood procurement chain from donor motivation to transfusion to the patient. Consent of donors and voluntary non-remunerated donation are fields which have been addressed by codes of ethics and legislation. Caring for donor health is an area of further development of ethical standards. In part, blood products have also become a market, where commercial principles may synergize, but also creating issues in equality and maintaining human dignity that challenge societal solutions. At the bedside, the main global challenge remains to procure enough blood products for each patient in medical need. Allocation of rare blood, ethical evaluation of transfusion triggers, attitudes towards refusing blood transfusion and provision of blood products to remote settings are areas which should receive consideration.
KW - Blood component recipient
KW - Blood components
KW - Blood donation
KW - Blood donors
KW - Ethics
KW - Plasma derivative medicinal products
KW - Transfusion medicine
UR - http://www.scopus.com/inward/record.url?scp=85151433743&partnerID=8YFLogxK
U2 - https://doi.org/10.1016/j.tracli.2023.03.004
DO - https://doi.org/10.1016/j.tracli.2023.03.004
M3 - Review article
C2 - 36965847
SN - 1246-7820
VL - 30
SP - 347
EP - 354
JO - Transfusion clinique et biologique
JF - Transfusion clinique et biologique
IS - 3
ER -